2025 HCPCS Code C1734
Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)
TAGS: opposing matrix| Short Description | Orth/devic/drug bn/bn,tis/bn | 
| HCPCS Action Code | N - No maintenance for this code | 
| HCPCS Coverage Code | D - Special coverage instructions apply | 
| HCPCS Code Added Date | January 01, 2020 | 
| HCPCS Action Effective Date | January 01, 2023 | 
| HCPCS Pricing Indicator Code | 53 - Statute | 
| HCPCS Type Of Service Code | 9 - Other medical items or services | 
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology | 
| HCPCS Anesthesia Base Unit Quantity | 0 | 
| HCPCS Coverage Issues Manual Reference Section Number | 
Check Similar HCPCS Codes
- C9015 - C-1 esterase, haegarda
- C9016 - Inj, triptorelin ext rel
- C9021 - Injection, obinutuzumab
- C9022 - Injection, elosulfase alfa
- C9023 - Inj testosterone undecanoate
- C9024 - Inj, daunorubicin-cytarabine
- C9025 - Injection, ramucirumab
- C9026 - Injection, vedolizumab
- C9027 - Injection, pembrolizumab
- C9028 - Inj. inotuzumab ozogamicin
- C9029 - Injection, guselkumab
- C9030 - Inj copanlisib
- C9031 - Lutetium lu 177 dotatate, tx
- C9032 - Voretigene neparvovec-rzyl
- C9033 - Inj, akynzeo
- C9034 - Injection, dexamethasone 9%
- C9035 - Injection, aristada initio
- C9036 - Injection, patisiran
- C9037 - Injection, risperidone
- C9038 - Inj mogamulizumab-kpkc
